Samsung has made it clear that the Health Monitor app’s irregular heart rhythm notification (IHGN) feature for Galaxy Watch devices has been approved by the US Food and Drug Administration. The feature, according to the company, can assist in identifying signs of atrial fibrillation (AFib), a type of arrhythmia, in addition to the electrocardiogram (ECG) capabilities of the wearable.
AFib is broadly accepted to be an alert for possibly major cardiovascular issues that can prompt expanded hazard of stroke, cardiovascular breakdown and different confusions. A few people with AFib don’t show any symptoms at all.
When the BioActive Sensor on the Galaxy Watch is activated in the Samsung Health Monitor app, it will look for irregular heart rhythms in the background. The watch will notify the wearer of potential AFib activity if the sensor detects several irregular measurements in a row. For a more precise measurement, the notification will recommend that the user take an ECG reading. The watch will advise the wearer to see a doctor if the reading reveals AFib symptoms.
Since 2019, every Apple Watch in certain markets has an IHGN feature, with the exception of the original model. According to Samsung, the market, carrier, model, and paired smartphone will all determine whether or not the IHGN feature is available.
Samsung will incorporate the IHGN highlight in the One UI 5 Watch update. It will initially be accessible on the following setup of Cosmic system Watch gadgets, which will show up in the not so distant future. Proprietors of Cosmic system Watch 4 series and later models will approach the component sometime in the future. The One UI 5 Watch will also include personalized heart rate zones for workouts and new sleep monitoring features.